(L to R) Jensen Huang, President and CEO of Nvidia Corporation, Google CEO Sundar Pichai and Mark Zuckerberg, CEO of Meta, arrive for a U.S. Senate bipartisan Artificial Intelligence Insight Forum at the US Capitol in Washington, D.C., on Sept. 13, 2023. Andrew Caballero-reynolds | Afp | Getty Images Seemingly every company is obsessed with … Read more
Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for free to receive it directly in your inbox. Here’s what CNBC TV’s producers were watching as the S & P 500 posted another record close, and what’s on the radar … Read more
Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it can live up to the hype. Icotyde went to market after the Food and Drug Administration approved it in mid-March for moderate to severe plaque psoriasis. The once-a-day drug is the first … Read more
CNBC’s Jim Cramer said Thursday investors should look beyond the market’s hottest trades and start hunting for opportunities in areas that have already been beaten down. “I want to praise the other parts of the market … that have been marked down already, which makes them less vulnerable,” the “Mad Money” host said. With the … Read more
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, and the remaining payments are contingent upon clinical, … Read more
Johnson & Johnson beat first-quarter earnings expectations on Tuesday and raised its full-year forecast, as strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more than offset a steep falloff in sales of its blockbuster autoimmune drug Stelara. And the company expressed confidence in its just-approved once-daily, oral psoriasis treatment, Icotyde, saying about 1,500 … Read more
Stocks staged a comeback on Monday as traders held out hope for a U.S.-Iran peace deal. The S&P 500 erased its losses since the start of the conflict. Source link
The earnings season kicks into high gear this week, at a time when investors may be starving for corporate guidance. There are 27 S & P 500 companies set to report, including banking giant such as JPMorgan Chase and Goldman Sachs, as well as Netflix and Johnson & Johnson. These reports come in the middle … Read more
As earnings season kicks off in earnest next week, companies like Morgan Stanley and Citizens Financial Group could exceed Wall Street’s expectations and see their shares climb as a result. The first-quarter reporting season begins next week, with 28 companies in the S & P 500 — nearly 6% of the index, and four of … Read more
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some companies are still feeling the effects. While some industries have emerged largely unscathed — having weathered twists and turns of several tariff iterations — others, such as retail, automotive, … Read more